简介:3-(2-Hydroxyphenyl)-6-(4-nitrophenyl)-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazine,C16H11N5O3S,waspreparedbythecyclizationof3-(2-hydroxyphenyl)-4-amino-5-mercapto-1,2,4-triazolewith2-bromo-4-nitroacetophenone.Thecompoundwascharacterizedbymeansofelementalanalysis,IR,1HNMR,13CNMR,massspectrometry,andX-raydiffraction.ThecompoundcrystallizesinamonoclinicsystemwithspacegroupCc,a=2.1853(4)nm,b=2.1192(5)nm,c=1.3526(3)nm,β=95.21(2)°,V=6.238(2)nm3,Dcalcd.=1.505Mg/m3,Z=16,F(000)=2916,R1=0.0501,wR2=0.0427.Acomparisonbetweenthecrystalstructuresof1,2,4-triazolo[3,4-b][1,3,4]thiadiazineand1,2,4-triazolo[3,4-b][1,3,4]thiadiazolewasmadeinthestructuralview.Atwo-dimensionalnetworkisformedbyhydrogenbondsandπ-πstackinginteractions.
简介:ThetabletunderdiscussionwasdiscoveredatUrandwaspublishedinUET6/ⅡasNo.398.ThetabletconsistsofafragmentofthemiddleportionofalateBabyloniantext,andpreservestheendportionofamythinwhichtheprincipleactorsarethegodsMardukandUras,andtoalesserextent,thegodEnlil.Thetextisinpoeticformwiththelinesfallingintocouplets,inwhichthesecondlineofeachcoupletusuallyformsaparallel,orasupplementtothefirstone.Thetext,hasbeenbrieflyoutlinedbyC.J.GaddinUET6/Ⅱ,buthasnotbeenotherwisepublishedtotheauthor'sknowledge,exceptforbriefcomments.
简介:MMA经溴化加成、醚化、催化裂化制得双甲醋;单氰胺与二硫化碳在碱性条件下缩合、甲基化制备二氰醋,后与正丙胺缩合再与水合肼环合,丙三唑与苯甲醛醛缩;醛缩物在缚酸剂下与双甲醋催化闭环生成环合物。再在盐酸中水解去醛基得三唑嘧啶酮成品。分别选择car1#、cat2#为裂解和闭环催化剂,反应收率分别达91.59%,91.98%,91.1%,86.6%,69.7%,总收率46.32%,产品纯度99.53%。
简介:目的探讨急性心肌梗死患者治疗前后血浆ET-1、血清6-酮-PGF1α、TXB2和GMP-140水平的变化及临床意义.方法应用放射免疫分析法对33例急性心肌梗死患者治疗前后进行了血浆ET-1、血清6-酮-PGF1α、TXB2和GMP-140水平测定,并与35名正常人作比较.结果急性心肌梗死患者在治疗前后血浆ET-1、TXB2和GMP-140水平非常显著地高于正常人组(P<0.01),而血清6-酮-PGF1α水平又明显低于正常人组(P<0.05),经治疗1个月后与正常人比较仍有差异(P<0.05).血浆ET-1水平和TXB2、GMP-140水平呈正相关(r=0.4986,0.5014,P<0.05),6-酮-PGF1α水平呈负相关(r=-0.4712,P<0.05).结论测定急性心肌梗死患者治疗前后血浆ET-1、血清6-酮-PGF1α、TXB2和GMP-140水平变化对观察病情和预后判定具有重要的临床价值.
简介:Twonovelcyclotriphosphazenederivativescontaining6-(4-hydroxyphenyl)-2,2'-bipyridine(hopbp)sidegroups,N_3P_3(dobp)_2(hopbp)_2(1)andN_3P_3(dobp)(hopbp)_4(2)(dobp=2,2'-dioxybiphenyl),weresynthesizedandcharacterized.Thesecompoundsdisplaystrongfluorescentemissionbothinsolutionandinsolidstate.Theirabsorptionandemissionspectraaresensitivetoproton:theadditionofHBF4tothemethanolanddichloromethanesolution(9∶1,volumeratio)ofcompound1ledtoared-shiftfrom350to460nmfortheemissionspectrum,andtheprocesswasalsocharacterizedbyisosbesticpointsofabsorptionspectraat267,287and313nm.
简介:以2,2,6,6-四甲基-4-羟基哌啶、烯丙基氯和氢氧化钠为原料催化合成4-烯丙氧基-2,2,6,6-四甲基哌啶,分别研究了反应时间、原料配比、溶剂用量和催化剂用量等条件对合成4-烯丙氧基-2,2,6,6-四甲基哌啶反应的影响,确定的最佳操作条件为:反应温度为45~54℃,反应时间5h,反应物摩尔比为:n(烯丙基氯)∶n(2,2,6,6-四甲基-4-羟基哌啶)∶n(氢氧化钠)为0.45∶0.1∶0.4,溶剂用量为10g,催化剂的用量为0.2g(2,2,6,6-四甲基-4-羟基哌啶为0.1mol),收率可达到95.43%以上,纯度为99.5%。